Display options
Cite
Kithsiri Wijeratne EM, Xu YM, Liu MX, et al. Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma. J Nat Prod. 2021;84(12):3029-3038doi: 10.1021/acs.jnatprod.1c00724.
Kithsiri Wijeratne, E. M., Xu, Y. M., Liu, M. X., Inacio, M. C., Brooks, A. D., Tewary, P., Sayers, T. J., & Gunatilaka, A. A. L. (2021). Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma. Journal of natural products, 84(12), 3029-3038. https://doi.org/10.1021/acs.jnatprod.1c00724
Kithsiri Wijeratne, E M, et al. "Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma." Journal of natural products vol. 84,12 (2021): 3029-3038. doi: https://doi.org/10.1021/acs.jnatprod.1c00724
Kithsiri Wijeratne EM, Xu YM, Liu MX, Inacio MC, Brooks AD, Tewary P, Sayers TJ, Gunatilaka AAL. Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma. J Nat Prod. 2021 Dec 24;84(12):3029-3038. doi: 10.1021/acs.jnatprod.1c00724. Epub 2021 Dec 01. PMID: 34851111.
Copy Download .nbib Format: NLM
Share it on

J Nat Prod. 2021 Dec 24;84(12):3029-3038. doi: 10.1021/acs.jnatprod.1c00724. Epub 2021 Dec 01.

Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma.

Journal of natural products

E M Kithsiri Wijeratne, Ya-Ming Xu, Manping X Liu, Marielle C Inacio, Alan D Brooks, Poonam Tewary, Thomas J Sayers, A A Leslie Gunatilaka

Affiliations

  1. Natural Products Center, School of Natural Resources and the Environment, College of Agriculture and Life Sciences, University of Arizona, 250 E. Valencia Road, Tucson, Arizona 85706, United States.
  2. Basic Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.
  3. Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, Maryland 21702, United States.

PMID: 34851111 DOI: 10.1021/acs.jnatprod.1c00724

Abstract

Physachenolide C (

Publication Types